Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Prior signed written informed from family member (no more needed following amendment in July 2016)~* 16 years of age or older~* Brain death diagnosis~* Left ventricular ejection fraction \< 50% determined by transthoracic echocardiography or hemodynamic instability defined as a mean dose of noradrenaline 0.1 mcg/kg/min + vasopressin~Exclusion Criteria:~* Heart failure history (removed after june 2015)~* Chronic exogenous oral T4 or T3 before death (removed after june 2015)~* Having received T4 infusion before recruitment(removed after june 2015)~* Echographic images not interpretable~  * Age 75 and older(removed after june 2015)~ * Prior coronary heart disease defined as prior coronary artery bypass graft or percutaneous coronary intervention (with or without stents)(removed after june 2015)

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Levothyroxine (Type: ACTIVE_COMPARATOR): Levothyroxine infusion 20 mg IV bolus then 10 mg/h infusion
- Placebo (Type: PLACEBO_COMPARATOR): Infusion matched to intervention arm

Based on this trial design, predict the completion outcome and termination type (if applicable).